Jump to:

News

RSS

Daxas: new therapy for the maintenance of COPD

Daxas (roflumilast) is a PDE4 inhibitor for use as an add-on to bronchodilator therapy in the maintenance of severe COPD.

Daxas: new therapy for the maintenance of COPD

New Drugs

Daxas: new therapy for the maintenance of COPD

Daxas (roflumilast) is a PDE4 inhibitor for use as an add-on to...

Thiotepa: alkylating agent for chemotherapy

Tepadina (thiotepa) is a cytotoxic treatment for haematological disease and solid tumours....

Capimune: new ciclosporin brand

Mylan has launched Capimune ( ciclosporin ), a new brand of ciclosporin...

Adoport: new tacrolimus brand

Adoport is a new brand of tacrolimus available from Sandoz. The 500...

Lanolin aerosol for dry skin

Evolve Plus is an emollient spray containing pure lanolin. The product has...

Licence Changes & Product Updates

Botox approved for migraine prevention

Botox (botulinum toxin type A) is the first agent to be specifically...

Paediatric indication for Metoject

Metoject (methotrexate) can now be prescribed in children from the age of...

Deleted products 2010

The following products have been discontinued from the UK market this year....

Diovan for paediatric use

Diovan (valsartan) 40mg and 320mg tablets have had their licences extended to...

New indication for Tyverb

Tyverb (lapatinib) has had its licence extended to include use in combination...

Guidelines & Clinical Updates

NICE approval for arthritis antibody

Patients with rheumatoid arthritis can now be treated with tocilizumab (RoActemra) on...

Antiarrhythmic accepted for limited NHS use

NICE has approved dronedarone (Multaq) as a second-line treatment for certain patients...

MHRA restricts quinine use

The MHRA has issued guidance that quinine should not be considered a...

Somatropin NICE approval extended

Somatropin (synthetic human growth hormone) can now be prescribed on the NHS...

MHRA advice on amphotericin B

The MHRA has reminded healthcare professionals that the use of lipid-based and...

 

Other Related News

Small consortia must share risk with neighbours, panel concludes

The size of consortia will not be important as long as risk...

Managers question GPC's NHS anti-privatisation stance

The GPC's stance against the use of private providers could be illegal...

GP consortia warned of cost of hiring PCT commissioners

GP consortia could face substantial payouts if they need to make ex-PCT...

Scottish government to enforce minimum alcohol price

The Scottish government has announced plans for a minimum alcohol price of...

Exclusive: Half of PCTs ignore bariatric surgery guidance

Over half of the UK's primary care organisations (PCOs) do not follow...

Latest MIMS Guidelines Summaries

Current Medical Standards of Fitness to Drive

Summary of DVLA guidance on fitness to drive. Adapted from 'For Medical...

Early Identification and Management of Chronic Kidney Disease in Adults

At-a-glance summary of NICE guidance for CKD diagnosis and treatment. Adapted from...

Management of Type 2 Diabetes

At-a-glance summary of NICE guidance for NIDDM treatment. Adapted from NICE Short...

Referral Guidelines for Breast Disorders

Adapted from: NHS Cancer Screening Programmes: Guidelines for referral of patients with...

Irritable Bowel Syndrome

At-a-glance summary of NICE guidance on irritable bowel syndrome. Adapted from NICE...

 

GP Curriculum Centre

Educational resource for the learning and teaching of the
GP curriculum

Click here to read more

Deleted products

Cumulative list of products discontinued from the UK market
in 2010

Click here to read more

Treating psoriasis

Healthcare Republic resource centre for diagnosing and managing psoriasis

Click here to read more

MIMs Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Find drugs by:

NICE Guidance: IBS

NICE Guidance: IBS

MIMS Summary of
NICE guideline

NICE Guidance: Lipid Modification

NICE Lipid Modification

MIMS Summary of
NICE guideline

Referral Guidelines for Breast Disorders

NHS Cancer Screening

MIMS Summary of NHS Cancer Screening Referral Guidelines

 

Back to top